Akebia Therapeutics, Inc.8月11日成交额为1168.63万美元

市场透视2025-08-12

美东时间2025年8月11日，Akebia Therapeutics, Inc.（AKBA.US）成交额为1168.63万美元，成交额较昨日减少38.15%，当日成交量为346.93万股。Akebia Therapeutics, Inc.（AKBA.US）于2025年8月11日跌2.05%，报3.35美元，该股过去5个交易日跌10.9%，年初至今涨76.32%，过去60日涨36.73%。|近5个...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2558549694?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-12 09:16","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2558549694","market":"us","top_or_hot":-1,"title":"Akebia Therapeutics, Inc.8月11日成交额为1168.63万美元","media":"市场透视","content":"<div>\n<p>美东时间2025年8月11日，Akebia Therapeutics, Inc.（AKBA.US）成交额为1168.63万美元，成交额较昨日减少38.15%，当日成交量为346.93万股。Akebia Therapeutics, Inc.（AKBA.US）于2025年8月11日跌2.05%，报3.35美元，该股过去5个交易日跌10.9%，年初至今涨76.32%，过去60日涨36.73%。|近5个...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091626a482e1c7&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Akebia Therapeutics, Inc.8月11日成交额为1168.63万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAkebia Therapeutics, Inc.8月11日成交额为1168.63万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-12 09:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091626a482e1c7&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美东时间2025年8月11日，Akebia Therapeutics, Inc.（AKBA.US）成交额为1168.63万美元，成交额较昨日减少38.15%，当日成交量为346.93万股。Akebia Therapeutics, Inc.（AKBA.US）于2025年8月11日跌2.05%，报3.35美元，该股过去5个交易日跌10.9%，年初至今涨76.32%，过去60日涨36.73%。|近5个...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091626a482e1c7&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091626a482e1c7&s=b","article_id":"2558549694","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091626a482e1c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2558549694","pubTimestamp":1754961379,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"美东时间2025年8月11日，Akebia Therapeutics, Inc.成交额为1168.63万美元，成交额较昨日减少38.15%，当日成交量为346.93万股。Akebia Therapeutics, Inc.于2025年8月11日跌2.05%，报3.35美元，该股过去5个交易日跌10.9%，年初至今涨76.32%，过去60日涨36.73%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|1168.63万|-38.15%|346.93万|#|2025-08-08|1889.61万|-58.32%|582.31万|#|2025-08-07|4533.22万|162.21%|1479.27万|#|2025-08-06|1728.83万|91.64%|464.02万|#|2025-08-05|902.14万|-4.35%|241.35万|Akebia Therapeutics Inc 是一家全集成生物制药公司。公司的运营部门是开发和商业化针对肾病患者的新型治疗药物的业务。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","AKBA":"Akebia Therapeutics, Inc.","BK4007":"制药","LENZ":"Therapeutics","BK4539":"次新股"},"translate_title":"Akebia Therapeutics, Inc. turnover of $11.6863 million on August 11","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AKBA":1,"LENZ":1},"content_text":"美东时间2025年8月11日，Akebia Therapeutics, Inc.（AKBA.US）成交额为1168.63万美元，成交额较昨日减少38.15%，当日成交量为346.93万股。Akebia Therapeutics, Inc.（AKBA.US）于2025年8月11日跌2.05%，报3.35美元，该股过去5个交易日跌10.9%，年初至今涨76.32%，过去60日涨36.73%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|1168.63万|-38.15%|346.93万|#|2025-08-08|1889.61万|-58.32%|582.31万|#|2025-08-07|4533.22万|162.21%|1479.27万|#|2025-08-06|1728.83万|91.64%|464.02万|#|2025-08-05|902.14万|-4.35%|241.35万|Akebia Therapeutics Inc 是一家全集成生物制药公司。公司的运营部门是开发和商业化针对肾病患者的新型治疗药物的业务。公司目前的产品组合包括 Auryxia（柠檬酸铁），这是一种在美国获批并上市的药物，用于控制依赖透析的慢性肾病成年患者的血清磷水平，以及治疗非透析依赖的慢性肾病成年患者的缺铁性贫血；还包括Vafseo（伐达他司）是一种口服缺氧诱导因子脯氨酸羟化酶抑制剂，已获日本批准用于治疗慢性肾病成年患者的贫血。此外，公司还在进行缺氧诱导因子脯氨酸羟化酶抑制剂（HIF-PH抑制剂）的临床前开发。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2558549694","isCrawlerRequest":true}